STOP: Iron Supplementation For Parkinson'S Disease Anemia

Overview

> Warning: Clinical Disclaimer: This STOP page represents a hypothesis based on mechanistic evidence and should NOT replace clinical judgment. Always consult with a qualified healthcare provider before modifying any treatment plan. Evidence quality ratings reflect the strength of the mechanistic reasoning, not RCT-level clinical proof.

References (4)

  1. ★Karen Pendergrass (2025). Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein Pathology. Conference Presentation. doi:10.5281/zenodo.17830083
  2. Karen Pendergrass (2025). Pendergrass 2025 — From Dysbiosis to Dyshomeostasis: Why Parkinson's Requires a Metallomic–Microbiome Lens. Zenodo Preprint. doi:10.5281/zenodo.18068369
  3. Yoram Finkelstein, Seth Bhatt, Danielle Bhatt (2022). Finkelstein 2022 -- Lead Exposure, Gut Microbiome, and Parkinson's Disease Risk. npj Parkinson's Disease. doi:10.1038/s41531-022-00351-6
  4. Jing Tan, Craig McKenzie, Maria Potamitis et al. (2023). Tan 2022 -- The Role of Short-Chain Fatty Acids in Health and Disease. Neuroscience Bulletin. doi:10.1007/s12264-023-01123-9

Related Articles